nodes	percent_of_prediction	percent_of_DWPC	metapath
Encainide—CYP2D6—Bicalutamide—prostate cancer	0.377	0.505	CbGbCtD
Encainide—CYP2D6—Abiraterone—prostate cancer	0.312	0.418	CbGbCtD
Encainide—CYP2D6—Doxorubicin—prostate cancer	0.0577	0.0773	CbGbCtD
Encainide—Bezafibrate—PPARA—prostate cancer	0.00461	0.198	CrCbGaD
Encainide—Zafirlukast—CYP2E1—prostate cancer	0.00224	0.096	CrCbGaD
Encainide—Zafirlukast—CYP2C19—prostate cancer	0.00222	0.0951	CrCbGaD
Encainide—Eletriptan—CYP2A6—prostate cancer	0.00193	0.0829	CrCbGaD
Encainide—Diltiazem—CYP3A5—prostate cancer	0.0017	0.0728	CrCbGaD
Encainide—Bezafibrate—CYP1A1—prostate cancer	0.00149	0.064	CrCbGaD
Encainide—Zafirlukast—CYP3A4—prostate cancer	0.00141	0.0605	CrCbGaD
Encainide—Eletriptan—CYP2C19—prostate cancer	0.00136	0.0583	CrCbGaD
Encainide—Clemastine—CYP3A4—prostate cancer	0.00128	0.0549	CrCbGaD
Encainide—Diltiazem—CYP2C19—prostate cancer	0.00116	0.0496	CrCbGaD
Encainide—Bezafibrate—CYP3A4—prostate cancer	0.000952	0.0408	CrCbGaD
Encainide—Eletriptan—CYP3A4—prostate cancer	0.000865	0.0371	CrCbGaD
Encainide—SCN5A—Axon guidance—PRNP—prostate cancer	0.000749	0.00325	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000745	0.00324	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	0.00074	0.00322	CbGpPWpGaD
Encainide—Diltiazem—CYP3A4—prostate cancer	0.000735	0.0315	CrCbGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	0.000731	0.00317	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—MAP2K1—prostate cancer	0.000722	0.00314	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—TGFB1—prostate cancer	0.00072	0.00313	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	0.000706	0.00306	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—EZR—prostate cancer	0.000705	0.00306	CbGpPWpGaD
Encainide—Thioridazine—CYP2E1—prostate cancer	0.000689	0.0296	CrCbGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000689	0.00299	CbGpPWpGaD
Encainide—Thioridazine—CYP2C19—prostate cancer	0.000683	0.0293	CrCbGaD
Encainide—CYP2D6—Metapathway biotransformation—EPHX1—prostate cancer	0.000665	0.00289	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	0.000657	0.00286	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	0.00065	0.00282	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	0.000649	0.00282	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NRP1—prostate cancer	0.000645	0.0028	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—HNF1B—prostate cancer	0.000645	0.0028	CbGpPWpGaD
Encainide—CYP2D6—Melatonin metabolism and effects—GSK3B—prostate cancer	0.000635	0.00276	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—prostate cancer	0.000634	0.00275	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000628	0.00273	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	0.000627	0.00272	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—prostate cancer	0.000626	0.00272	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	0.000623	0.00271	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP7B1—prostate cancer	0.000617	0.00268	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	0.000615	0.00267	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP7B1—prostate cancer	0.000608	0.00264	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—SULT1E1—prostate cancer	0.000601	0.00261	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	0.0006	0.00261	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	0.000595	0.00258	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—SULT1E1—prostate cancer	0.000593	0.00257	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—HSP90AB1—prostate cancer	0.000587	0.00255	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	0.000586	0.00255	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	0.000578	0.00251	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	0.000572	0.00248	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	0.000566	0.00246	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—PRNP—prostate cancer	0.000535	0.00232	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	0.000533	0.00231	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP3A5—prostate cancer	0.000529	0.0023	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MED12—prostate cancer	0.000526	0.00228	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP3A5—prostate cancer	0.000522	0.00227	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—prostate cancer	0.000514	0.00223	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000513	0.00223	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTA3—prostate cancer	0.000511	0.00222	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	0.000505	0.00219	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTA3—prostate cancer	0.000504	0.00219	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NCOA3—prostate cancer	0.000503	0.00218	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SRC—prostate cancer	0.000501	0.00218	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—PRKCQ—prostate cancer	0.0005	0.00217	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	0.000482	0.00209	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	0.000475	0.00206	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	0.000472	0.00205	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTA4—prostate cancer	0.000467	0.00203	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—TBXAS1—prostate cancer	0.000467	0.00203	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	0.000466	0.00202	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTA4—prostate cancer	0.000461	0.002	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	0.000458	0.00199	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—VAV3—prostate cancer	0.000458	0.00199	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTA2—prostate cancer	0.000455	0.00198	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—SULT1A1—prostate cancer	0.00045	0.00195	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—SULT1A1—prostate cancer	0.000444	0.00193	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTA1—prostate cancer	0.000439	0.00191	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—EGFR—prostate cancer	0.000439	0.00191	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—NAT2—prostate cancer	0.000434	0.00189	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTO1—prostate cancer	0.000434	0.00189	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—NAT2—prostate cancer	0.000428	0.00186	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTO1—prostate cancer	0.000428	0.00186	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NCOA2—prostate cancer	0.00042	0.00182	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP2C18—prostate cancer	0.000417	0.00181	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP2C18—prostate cancer	0.000411	0.00178	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000407	0.00177	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—ITGB3—prostate cancer	0.000394	0.00171	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.00039	0.00169	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—SULT2A1—prostate cancer	0.000387	0.00168	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	0.000383	0.00166	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—SULT2A1—prostate cancer	0.000382	0.00166	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000376	0.00163	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GPX3—prostate cancer	0.000364	0.00158	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—PRKCQ—prostate cancer	0.000357	0.00155	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NCOA1—prostate cancer	0.000354	0.00154	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000349	0.00152	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—HPGDS—prostate cancer	0.000347	0.00151	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP2C19—prostate cancer	0.000345	0.0015	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP2C19—prostate cancer	0.00034	0.00148	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—FGF10—prostate cancer	0.000339	0.00147	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTT1—prostate cancer	0.000337	0.00146	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—RXRA—prostate cancer	0.000336	0.00146	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—KDR—prostate cancer	0.000335	0.00145	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP2A6—prostate cancer	0.000333	0.00145	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000331	0.00144	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—VAV3—prostate cancer	0.000327	0.00142	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—AKR1C3—prostate cancer	0.000319	0.00139	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP17A1—prostate cancer	0.000319	0.00138	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP17A1—prostate cancer	0.000314	0.00137	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—NCOA2—prostate cancer	0.000304	0.00132	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—GSK3B—prostate cancer	0.000296	0.00128	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—LPL—prostate cancer	0.000291	0.00126	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP2E1—prostate cancer	0.000283	0.00123	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ITGB3—prostate cancer	0.000281	0.00122	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP2E1—prostate cancer	0.000279	0.00121	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—MMP2—prostate cancer	0.000273	0.00119	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP3A4—prostate cancer	0.000273	0.00119	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—MAP2K1—prostate cancer	0.000273	0.00118	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP3A4—prostate cancer	0.000269	0.00117	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP1B1—prostate cancer	0.000268	0.00117	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP1B1—prostate cancer	0.000265	0.00115	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GGT1—prostate cancer	0.00026	0.00113	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—PPARA—prostate cancer	0.000257	0.00112	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—NCOA1—prostate cancer	0.000256	0.00111	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP19A1—prostate cancer	0.000252	0.0011	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP19A1—prostate cancer	0.000249	0.00108	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—JAK2—prostate cancer	0.000249	0.00108	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—LEP—prostate cancer	0.000244	0.00106	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—RXRA—prostate cancer	0.000244	0.00106	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—ERBB2—prostate cancer	0.000239	0.00104	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—KDR—prostate cancer	0.000239	0.00104	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—COMT—prostate cancer	0.000235	0.00102	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTP1—prostate cancer	0.000233	0.00101	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—COMT—prostate cancer	0.000231	0.001	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTP1—prostate cancer	0.00023	0.001	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000229	0.000994	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTM1—prostate cancer	0.000215	0.000932	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTM1—prostate cancer	0.000212	0.000919	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—GSK3B—prostate cancer	0.000211	0.000917	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—INS—prostate cancer	0.000208	0.000904	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—MMP9—prostate cancer	0.000205	0.000892	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CREBBP—prostate cancer	0.000204	0.000886	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP1A1—prostate cancer	0.000203	0.000883	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HAO1—prostate cancer	0.000201	0.000872	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP1A1—prostate cancer	0.000201	0.000871	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MMP2—prostate cancer	0.000195	0.000847	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MAP2K1—prostate cancer	0.000195	0.000845	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SRC—prostate cancer	0.000189	0.000822	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—FGF2—prostate cancer	0.000185	0.000804	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—VEGFA—prostate cancer	0.000184	0.000801	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—JAK2—prostate cancer	0.000177	0.000771	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ERBB2—prostate cancer	0.000171	0.000742	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—EGFR—prostate cancer	0.000166	0.000721	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PSAT1—prostate cancer	0.000164	0.000711	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CBR1—prostate cancer	0.000164	0.000711	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CSAD—prostate cancer	0.000164	0.000711	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ADI1—prostate cancer	0.000164	0.000711	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GRHL1—prostate cancer	0.000164	0.000711	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TST—prostate cancer	0.000164	0.000711	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—KRAS—prostate cancer	0.000157	0.000681	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—UGT2B15—prostate cancer	0.000152	0.000661	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—UGT2B17—prostate cancer	0.000152	0.000661	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CKMT2—prostate cancer	0.000152	0.000661	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GRHPR—prostate cancer	0.000152	0.000661	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CTNNB1—prostate cancer	0.000149	0.000649	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MMP9—prostate cancer	0.000147	0.000636	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTM3—prostate cancer	0.000143	0.000621	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SULT2B1—prostate cancer	0.000143	0.000621	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—RFK—prostate cancer	0.000143	0.000621	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PGAM2—prostate cancer	0.000143	0.000621	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—AOX1—prostate cancer	0.000143	0.000621	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NAGLU—prostate cancer	0.000143	0.000621	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—MBTPS1—prostate cancer	0.000143	0.000621	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—EP300—prostate cancer	0.000139	0.000603	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—AMACR—prostate cancer	0.000136	0.000589	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SRD5A2—prostate cancer	0.000136	0.000589	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP3A43—prostate cancer	0.000136	0.000589	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NAT1—prostate cancer	0.000136	0.000589	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—DEGS1—prostate cancer	0.000136	0.000589	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SRC—prostate cancer	0.000135	0.000587	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—VEGFA—prostate cancer	0.000132	0.000571	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—STAT3—prostate cancer	0.00013	0.000566	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HSD17B1—prostate cancer	0.000129	0.000562	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—IL6—prostate cancer	0.000128	0.000554	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—TGFB1—prostate cancer	0.000121	0.000524	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—EGFR—prostate cancer	0.000118	0.000514	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HPGD—prostate cancer	0.000115	0.000501	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—B4GALT4—prostate cancer	0.000115	0.000501	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—KRAS—prostate cancer	0.000112	0.000486	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TNFRSF21—prostate cancer	0.000108	0.000471	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—MTAP—prostate cancer	0.000105	0.000458	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP7B1—prostate cancer	0.000105	0.000458	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SRD5A1—prostate cancer	0.000103	0.000446	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SULT1E1—prostate cancer	0.000103	0.000446	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ACSL4—prostate cancer	9.8e-05	0.000426	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HSD17B3—prostate cancer	9.8e-05	0.000426	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PHGDH—prostate cancer	9.4e-05	0.000408	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—UMPS—prostate cancer	9.4e-05	0.000408	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ARG2—prostate cancer	9.4e-05	0.000408	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—LDHB—prostate cancer	9.22e-05	0.0004	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—IL6—prostate cancer	9.1e-05	0.000395	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP3A5—prostate cancer	9.05e-05	0.000393	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTA3—prostate cancer	8.74e-05	0.000379	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TCN2—prostate cancer	8.74e-05	0.000379	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PDHA1—prostate cancer	8.74e-05	0.000379	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—UCP3—prostate cancer	8.74e-05	0.000379	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—AKT1—prostate cancer	8.39e-05	0.000365	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC22A3—prostate cancer	8.34e-05	0.000362	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HSD3B1—prostate cancer	8.34e-05	0.000362	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TBXAS1—prostate cancer	7.99e-05	0.000347	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTA4—prostate cancer	7.99e-05	0.000347	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTA2—prostate cancer	7.79e-05	0.000338	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SULT1A1—prostate cancer	7.69e-05	0.000334	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ABCG5—prostate cancer	7.69e-05	0.000334	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTA1—prostate cancer	7.51e-05	0.000326	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTO1—prostate cancer	7.43e-05	0.000323	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NAT2—prostate cancer	7.43e-05	0.000323	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HSD3B2—prostate cancer	7.43e-05	0.000323	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PLCB2—prostate cancer	7.12e-05	0.000309	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP2C18—prostate cancer	7.12e-05	0.000309	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—LRP2—prostate cancer	7.12e-05	0.000309	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—P4HB—prostate cancer	6.99e-05	0.000303	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC22A1—prostate cancer	6.8e-05	0.000295	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SULT2A1—prostate cancer	6.62e-05	0.000288	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—MED12—prostate cancer	6.51e-05	0.000283	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GNG5—prostate cancer	6.46e-05	0.000281	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NCOA3—prostate cancer	6.23e-05	0.00027	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HPGDS—prostate cancer	5.94e-05	0.000258	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP2C19—prostate cancer	5.9e-05	0.000256	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTT1—prostate cancer	5.76e-05	0.00025	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ACHE—prostate cancer	5.76e-05	0.00025	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.69e-05	0.000247	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—AKR1C3—prostate cancer	5.54e-05	0.000241	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PRKACB—prostate cancer	5.51e-05	0.000239	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.45e-05	0.000237	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NCOA2—prostate cancer	5.2e-05	0.000226	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC5A5—prostate cancer	4.96e-05	0.000215	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.84e-05	0.00021	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NQO1—prostate cancer	4.79e-05	0.000208	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TH—prostate cancer	4.72e-05	0.000205	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.67e-05	0.000203	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.59e-05	0.000199	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GGT1—prostate cancer	4.45e-05	0.000193	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NCOA1—prostate cancer	4.38e-05	0.00019	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.32e-05	0.000187	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—RXRA—prostate cancer	4.16e-05	0.000181	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—COMT—prostate cancer	4.01e-05	0.000174	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTP1—prostate cancer	3.99e-05	0.000173	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ITPR1—prostate cancer	3.93e-05	0.000171	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TYMS—prostate cancer	3.71e-05	0.000161	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTM1—prostate cancer	3.67e-05	0.000159	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—LPL—prostate cancer	3.6e-05	0.000156	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.48e-05	0.000151	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ERCC2—prostate cancer	3.45e-05	0.00015	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—MTHFR—prostate cancer	3.24e-05	0.000141	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PPARA—prostate cancer	3.18e-05	0.000138	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CAV1—prostate cancer	2.99e-05	0.00013	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.72e-05	0.000118	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—INS—prostate cancer	2.58e-05	0.000112	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CREBBP—prostate cancer	2.53e-05	0.00011	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.4e-05	0.000104	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NOS3—prostate cancer	2.26e-05	9.82e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.09e-05	9.07e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PTGS2—prostate cancer	2.07e-05	8.98e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PTEN—prostate cancer	1.8e-05	7.84e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—EP300—prostate cancer	1.72e-05	7.47e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.27e-05	5.53e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—AKT1—prostate cancer	1.04e-05	4.52e-05	CbGpPWpGaD
